Who owns BIOMARIN PHARMACEUTICAL INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BMRN from SEC Form 13F filings across 558 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 558 institutions disclosed 193.8M shares of BIOMARIN PHARMACEUTICAL INC worth $12.00B — about 100.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
558
13F holders
$12.00B
value, 2026 filers
100.2%
of shares outstanding (193.8M sh)
96
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BMRN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 20.4M | $1.17B | 0.0% | 10.6% | +3.2% |
| 2 | Dodge & Cox | 14.8M | $849.4M | 0.4% | 7.7% | +1.9% |
| 3 | PRIMECAP MANAGEMENT CO/CA/ | 14.2M | $812.0M | 0.5% | 7.3% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 8.7M | $500.3M | 0.0% | 4.5% | +1.2% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.6M | $494.9M | 0.0% | 4.5% | +4.2% |
| 6 | NORGES BANKNEW | 8.2M | $469.7M | 0.0% | 4.2% | new |
| 7 | STATE STREET CORP | 7.8M | $446.4M | 0.0% | 4% | +6.9% |
| 8 | VIKING GLOBAL INVESTORS LP | 7.6M | $435.8M | 1.2% | 3.9% | +7.9% |
| 9 | Vestal Point Capital, LP | 6.0M | $344.8M | 8.1% | 3.1% | +68.5% |
| 10 | AQR CAPITAL MANAGEMENT LLC | 5.7M | $322.5M | 0.1% | 2.9% | -25.8% |
| 11 | FMR LLC | 4.8M | $276.0M | 0.0% | 2.5% | +35.2% |
| 12 | DIMENSIONAL FUND ADVISORS LP | 4.1M | $233.2M | 0.0% | 2.1% | +7.2% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 3.9M | $223.9M | 0.0% | 2% | +2.4% |
| 14 | Capital Research Global Investors | 3.5M | $200.5M | 0.0% | 1.8% | +0.4% |
| 15 | Deep Track Capital, LP | 3.3M | $189.3M | 2.8% | 1.7% | +187.6% |
| 16 | MILLENNIUM MANAGEMENT LLC | 2.1M | $118.5M | 0.0% | 1.1% | -31.2% |
| 17 | Assenagon Asset Management S.A. | 1.8M | $100.8M | 0.1% | 0.9% | -8.3% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.6M | $92.5M | 0.0% | 0.8% | +1.8% |
| 19 | FIRST TRUST ADVISORS LP | 1.6M | $91.9M | 0.1% | 0.8% | -4.0% |
| 20 | NORTHERN TRUST CORP | 1.6M | $89.2M | 0.0% | 0.8% | -1.8% |
| 21 | MORGAN STANLEY | 1.5M | $86.1M | 0.0% | 0.8% | +13.9% |
| 22 | Jones Hill Capital LP | 1.4M | $81.9M | 17.4% | 0.7% | +12.9% |
| 23 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.3M | $76.3M | 0.8% | 0.7% | +56.5% |
| 24 | Swedbank AB | 1.3M | $75.2M | 0.1% | 0.7% | +66.0% |
| 25 | UBS Group AG | 1.3M | $73.6M | 0.0% | 0.7% | -14.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.